Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.

ABSTRACT:

SUBMITTER: Meynaar IA 

PROVIDER: S-EPMC9171741 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature